Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid.
Photodynamic therapy (PDT) using topical delta-aminolevulinic acid (ALA) has been used for nonmelanoma skin cancers, including malignant cutaneous T-cell lymphomas. Moreover, PDT has been tried for benign inflammatory or infectious skin lesions. To evaluate the effects of ALA-PDT on skin lesions of lymphadenosis benigna cutis (LABC). Two 16-year-old females with solitary and infiltrated nodules were treated 5 times with topical ALA-PDT. Both patients responded well and showed dramatic clinical and histopathological improvement without visible scars. The results confirm that topical ALA-PDT is an effective and safe modality for the treatment of LABC, and that such treatment may be cosmetically beneficial.